Solution Structures of the SURP Domains and the Subunit-Assembly Mechanism within the Splicing Factor SF3a Complex in 17S U2 snRNP  by Kuwasako, Kanako et al.
Structure 14, 1677–1689, November 2006 ª2006 Elsevier Ltd All rights reserved DOI 10.1016/j.str.2006.09.009Solution Structures of the SURP Domains and the
Subunit-Assembly Mechanism within the Splicing
Factor SF3a Complex in 17S U2 snRNPKanako Kuwasako,1,5 Fahu He,1,5 Makoto Inoue,1
Akiko Tanaka,1 Sumio Sugano,3 Peter Gu¨ntert,1,2
Yutaka Muto,1,* and Shigeyuki Yokoyama1,4,*
1Protein Research Group
2Tatsuo Miyazawa Memorial Program
RIKEN Genomic Sciences Center
Yokohama 230-0045
Japan
3Laboratory of Functional Genomics
Department of Medical Genome Sciences
Graduate School of Frontier Sciences
The University of Tokyo
4-6-1 Shirokanedai, Minato-ku
Tokyo, 108-8639
Japan
4Department of Biophysics and Biochemistry
Graduate School of Sciences
The University of Tokyo
Tokyo 113-0033
Japan
Summary
The SF3a complex, consisting of SF3a60, SF3a66, and
SF3a120, in 17S U2 snRNP is crucial to spliceosomal
assembly. SF3a120 contains two tandem SURP do-
mains (SURP1 and SURP2), and SURP2 is responsible
for binding to SF3a60. We found that the SURP2 frag-
ment forms a stable complex with an SF3a60 fragment
(residues 71–107) and solved its structure by NMR
spectroscopy. SURP2 exhibits a fold of the a1-a2-310-
a3 topology, and the SF3a60 fragment forms an amphi-
pathic a helix intimately contacting a1 of SURP2. We
also solved the SURP1 structure, which has the same
fold as SURP2. The protein-binding interface of
SURP2 is quite similar to the corresponding surface
of SURP1, except for two amino acid residues. One of
them, Leu169, is characteristic of SF3a120 SURP2
among SURP domains. Mutagenesis showed that this
single Leu residue is the critical determinant for com-
plex formation, which reveals the protein recognition
mechanism in the subunit assembly.
Introduction
mRNA splicing is an essential event in the posttranscrip-
tional process of gene expression and is thought to be
regulated by hundreds of splicing-associated proteins
(Dziembowski et al., 2004; Hastings and Krainer, 2001;
Jurica and Moore, 2003; Nilsen, 2003; Varani and Nagai,
1998; Will et al., 2002; Zhu and Krainer, 2000). Splicing
occurs through two successive trans-esterification
reactions. In step 1, the conserved adenosine in the
branch site cleaves the 50 splice site by a nucleophilic
*Correspondence: yokoyama@biochem.s.u-tokyo.ac.jp (S.Y.),
ymuto@gsc.riken.jp (Y.M.)
5 These authors contributed equally to this work.attack, and in step 2, the 50 splice site attacks the 30 splice
site to release the intron (Query et al., 1994). These se-
quential reactions are carried out by the spliceosome,
a large and highly dynamic macromolecular complex
containing a series of small nuclear ribonucleoproteins,
the U1, U2, U4, U5, and U6 snRNPs (Jurica and Moore,
2003; Nilsen, 2003; Staley and Guthrie, 1998). Each of
the snRNPs contains a small nuclear RNA (U snRNA)
and protein components (Jurica and Moore, 2003;
Kra¨mer, 1996).
The U2 snRNP, an essential component of the spliceo-
some, binds to the pre-mRNA branch site via base-pair-
ing with the complementary RNA sequence of the U2
snRNA and interacts with the U1 snRNP that binds to
the 50 splice site (Michaud and Reed, 1991; Se´raphin
et al., 1988; Zhuang and Weiner, 1986). This U1
snRNPU2 snRNPpre-mRNA ternary complex recruits
the U4/U6U5 tri-snRNPs and forms the functionally
active spliceosome, which catalyzes the two trans-
esterification reactions (Jurica and Moore, 2003; Nilsen,
2003). The U2 snRNP is a large protein-RNA complex
containing the core 12S U2 snRNP particle (the U2
snRNA, the Sm core proteins, and the U2A0 and U2B00
complex) (Caspary and Se´raphin, 1998; Kambach et al.,
1999; Lu¨hrmann et al., 1990; Price et al., 1998; Raker
et al., 1996; Scherly et al., 1990; Tang et al., 1996) and
the SF3a and SF3b protein complexes (Brosi et al.,
1993; Das et al., 1999; Gozani et al., 1996; Will et al.,
2002). The core 12S U2 snRNP particle binds to SF3b to
form the pre-mature 15S U2 snRNP (Figure 2A) (Nesic
and Kra¨mer, 2001). Furthermore, the pre-mature 15S U2
snRNP binds to SF3a to form the functionally mature
17S U2 snRNP (Figure 2A) (Nesic and Kra¨mer, 2001).
Upon binding of the 17S U2 snRNP to the pre-mRNA,
all of the SF3a components interact with a regionw25 nu-
cleotides upstream of the branch site and are necessary
for the successive spliceosomal assembly (Gozani et al.,
1996). Thus, the SF3a complex is a crucial component for
the formation of the functionally active 17S U2 snRNP.
The SF3a complex is composed of three proteins:
SF3a60, SF3a66, and SF3a120 (Chiara et al., 1994;
Kra¨mer et al., 1994, 1995; Legrain and Chapon, 1993; Ne-
sic and Kra¨mer, 2001; Wiest et al., 1996). The SF3a60 and
SF3a66 proteins each contain a zinc-finger domain (Fig-
ure 2B) (Nesic and Kra¨mer, 2001). SF3a120 contains two
tandem SURP domains (referred to as SURP1 and
SURP2, hereafter) and a ubiquitin domain (Figure 2B)
(Kra¨mer et al., 1995). There are no other known motifs
among the components of the SF3a complex. Far-west-
ern blotting analyses indicated that SF3a60 and SF3a66
interact with SF3a120, but not with each other (Nesic and
Kra¨mer, 2001). Namely, the N-terminal region (1–216) of
SF3a66, excluding the zinc-finger domain, binds to
a segment (residues 243–372) of SF3a120; none of the
known domains mediates this interaction. On the other
hand, a segment (residues 35–107) of SF3a60 binds to
the SF3a120 SURP2. Therefore, SF3a120 is a pivotal
molecule for the formation of the ternary complex.
The SURP domain, also known as the SWAP domain,
was first found as two repeated sequence motifs in
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1678Figure 1. Sequence Alignment of SURP1 and SURP2 in SF3a120 and SURP1 in Human SWAP
Yellow backgrounds and asterisks indicate highly conserved residues among the SURP domains, and a black background with yellow letters
indicates the conserved phenylalanine among all of the SURP domains, as shown in Figure 8B. The critical position for complex formation is
indicated by a red arrowhead, and the colors reflect the amino acid type: red, blue, and green letters represent hydrophobic (protein-binding
type), charged, and neutral (S, T, and Q) amino acids, respectively. The hydrophobic-core-forming residues are indicated by filled circles,
and the residues that interact with the core residues are indicated by open circles. Red stars and red open stars indicate the hydrophobic-
and hydrophilic-complex-forming residues in SURP2 of SF3a120, respectively.a splicing regulator, Suppressor-of-White-Apricot from
Drosophila melanogaster (Denhez and Lafyatis, 1994;
Spikes et al., 1994). The exclusive appearance of
SURP domains in splicing-associated proteins indicates
that this motif emerged in concordance with the appear-
ance of pre-mRNA splicing (Denhez and Lafyatis, 1994;
Kra¨mer et al., 1995; Sampson and Hewitt, 2003; Will
et al., 2002). In addition, several recent lines of evidence
indicated that the SURP-containing proteins play impor-
tant roles in spliceosomal assembly (Nesic and Kra¨mer,
2001; Sarkissian et al., 1996; Utans and Kra¨mer, 1990;
Will et al., 2002). Despite the functional importance of
SURP-containing proteins, nothing is known about the
properties of the SURP domains, except for the
SF3a120 SURP2.
To elucidate the structural basis for the specific inter-
action between the SF3a120 SURP2 and SF3a60, we
determined the solution structure of human SF3a120
SURP2 in complex with the fragment bearing residues
71–107 of SF3a60 by heteronuclear NMR spectroscopy.
We also determined the solution structure of human
SF3a120 SURP1 and compared the two SURP domains.
Furthermore, we identified a single Leu residue (Leu169)
of SURP2 that is responsible for the protein-binding ac-
tivity, by structural and mutational analyses. As far as we
know, this study is the first report of the SURP domain
structure and its protein-recognition mode, as well as
the first structural description of the subunit interactions
in the SF3a complex.
Results
Identification of a Soluble Form of the SURP
Domains from Human SF3a120
Based on the sequence alignment, we predicted that the
two SURP domains of human SF3a120 are residues 48–
110 (SURP1) and 158–217 (SURP2), respectively (Figures1 and 2B). For structural studies on the two SURP do-
mains of SF3a120, we constructed expression vectors
for recombinant GST- or His-tagged SF3a120 fragments,
spanning residues 48–110, 48–157, 48–217, 111–157,
111–217, and 158–217 (Figure 2C). Among them, the
two SF3a120 fragments that contained SURP1 (48–110
and 48–157) were soluble. Therefore, we concluded
that the SURP1 domain alone (48–110) (see Figure 2C)
was suitable for the structural determination by NMR
(see also Experimental Procedures).
On the other hand, two SF3a120 fragments (111–217
and 157–217) containing SURP2 were not expressed as
His-tagged proteins in E. coli cells and were insoluble
when expressed as GST-tagged proteins (Figure 2C).
As described above, the region containing SURP2 in
SF3a120 interacts with the SF3a60 fragment (35–107)
(Nesic and Kra¨mer, 2001). We speculated that direct
binding of the SURP2 domain to a specific region within
the SF3a60 fragment (35–107) is necessary for the solu-
ble and stable expression. Similarly to SURP2, the
SF3a60 fragment (1–107) alone was not soluble when ex-
pressed in E. coli cells (Figure 2D). Therefore, we estab-
lished an E. coli coexpression system of the GST-tagged
human SF3a60 (1–107) protein with several His-tagged
SF3a120 fragments (48–217, 111–157, 111–217, and
158–217, respectively) (Figure 2E), to examine whether
they formed a complex and remained soluble. From the
four coexpression systems, two SF3a120 fragments
(48–217 and 111–217) that contain SURP2 (158–217)
with N-terminal extensions (48–157 or 111–157) were ob-
tained as soluble forms in complex with the SF3a60 frag-
ment (Figure 2E). Furthermore, we examined the com-
plex formation activity for several lengths of SF3a120
and SF3a60 fragments and found that the combination
of SF3a120 (134–217) and SF3a60 (71–107) was the min-
imum size complex of the fragments examined (Fig-
ure 2E) and that it was suitable for the structure analysis.
Solution Structure of SURP Domains in SF3a120
1679Figure 2. The cDNA Constructs Providing Soluble Recombinant Proteins
(A) Schematic diagram of the maturation process of U2 snRNP. Red lines indicate the U2 snRNA.
(B) Schematic diagrams of the domain structures of human SF3a60, SF3a66, and SF3a120. SURP, ubiquitin, and zinc-finger domains are
represented with pink, yellow, and blue boxes, respectively.
(C) Solubility of each of the SF3a120 fragments expressed alone in E. coli cells. The red arrowhead indicates that this fragment was used for the
solution structure analysis of SURP1. The solubility of the recombinant proteins is represented in (C), (D), and (E) as follows: plus and minus
indicate soluble and insoluble proteins, respectively. N.A. indicates that the fragments were not expressed.
(D) Solubility of each of the SF3a60 fragments expressed alone in E. coli cells.
(E) Solubility of the His-tagged SF3a120 fragments coexpressed with various lengths of the GST-tagged SF3a60 fragments in E. coli cells. The
red arrowhead indicates that this combination of fragments was used for the solution structure analysis of the SURP2-SF3a60 complex.
Structure
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Using standard multidimensional heteronuclear NMR
spectroscopy, we assigned the main-chain and side-
chain resonances (see Experimental Procedures);
95.3% (48–110) of the main chain and 98.4% (48–110)
of the side chains were successfully assigned. We deter-
mined the solution structure of SURP1 on the basis of the
1867 1H-1H distance constraints from nuclear Over-
hauser effect spectroscopy (NOESY) and 79 torsion
angle restraints (Table 1). Out of the 100 independently
calculated structures, the 20 lowest-energy conformers
were used for further analyses.
The overall structure of the SURP1 domain adopts
a compact fold, comprising three main a helices and
one short 310-helix, with an a1-a2-310-a3 topology
(Figure 3A). The three main a helices, a1, a2, and a3,
are formed by residues Glu48-Asn63, Glu66-Asn74,
and His91-Glu103, respectively (Figures 1 and 3B). The
Table 1. Summary of Conformational Constraints and Structural
Statistics for the 20 Energy-Refined Conformers of the SURP1
Domain and SURP2–SF3a60 Complex Structures
SURP1 SURP2-SF3a60
NMR Distance and Dihedral Angle Constraints
Distance constraints
Total NOE 1867 2571
Intraresidue 421 696
Interresidue
Sequential (ji2jj = 1) 518 658
Medium range (1 < ji2jj < 4) 545 672
Long range (ji2jjR 5) 383 545
Intermolecular — 203
Hydrogen bonds 0 6
f/c dihedral angle constraints
(TALOSa)
79 118
CYANA target function (A˚2) 0.12 6 0.02 0.17 6 0.05
Structure Statistics
Residual NOE violations
Number > 0.10 A˚ 2 2
Maximum (A˚) 0.11 0.11
Residual dihedral angle violations
Number > 2.5 0 0
Maximum () 0.51 1.36
AMBER energiesb (kcal/mol)
Total 23117 6 49 24721 6 85
van der Waals 2199 6 7 2287 6 16
Electrostatic 23386 6 48 25329 6 99
Ramachandran plot statisticsc,d (%)
Residues in most favored
regions
96.2 95.4
Residues in additionally
allowed regions
3.6 4.6
Residues in generously
allowed regions
0.2 0.0
Residues in disallowed
regions
0.0 0.0
Average rmsd from mean coordinatesc (A˚)
Backbone 0.23 0.34
Heavy atoms 0.60 0.78
a Cornilescu et al. (1999).
b Cornell et al. (1995).
c For the structured regions comprising residues 48–103 of the
SURP1 domain and residues 160–214 and 80p–96p of the SURP2-
SF3a60 complex.
d Laskowski et al. (1996).310 helix is formed by Pro79-Leu84 (Figures 1 and 3B).
The a1 and a3 helices are located close together in
a parallel manner and face the a2 helix across the 310
helix in an antiparallel orientation (Figure 3B).
The 310 helix serves as a scaffold for spatially position-
ing the a helices in the compact conformation, with the
hydrophobic amino acids (Phe81, Phe83, and Leu84)
playing important roles (Figure 4A): the Phe83 and
Leu84 residues in the 310 helix and the Tyr94 residue in
the a3 helix form the hydrophobic core (Figure 4A). Res-
idues in the a1 (Ile52, Thr56, and Val60), a2 (Glu68 and
Ile71), a3 (His91 and Val98), and 310 helices (Phe81) con-
tact the core residues (Figure 4A). Furthermore, Phe81,
in the 310 helix, anchors Ile71 and Glu75 in the a2 helix.
In addition, intimate contacts are observed in the a1
and a3 helices; namely, Tyr93 and Tyr94 of the a3 helix
embrace Val53 of the a1 helix (Figure 4A). Collectively,
these interactions among the helices reinforce their
spatial relationships and maintain the compact folding
of the SURP domain.
The Complex Structure of SURP2 and the Peptide
from the SF3a60 Subunit
We solved the structure of the SF3a120 fragment
(134–217) containing SURP2 complexed with SF3a60
(71–107) by heteronuclear multidimensional NMR (see
Experimental Procedures). As a result, 96.5% (134–217)
of the main chain and 97.6% (134–217) of the side chains
of SF3a120 and 94.7% (71–107) of the main chain and
97.4% (71–107) of the side chains of SF3a60 were suc-
cessfully assigned. From the complex, 2571 NOESY-
based distance constraints and 118 torsion angle
restraints were obtained (Table 1). In addition, 203 inter-
molecular distance constraints were included in the
structure calculation. Out of the 100 independently cal-
culated structures, the 20 lowest-energy conformers
were further analyzed. Even though the N-terminal ex-
tension (134–157) of SURP2 is necessary to produce
a soluble complex as described above, this region pro-
vided no distance constraints with the SF3a60 fragment
and does not contribute to complex formation.
The SURP domain in complex with SF3a60 (71–107)
adopts essentially the same tertiary structure as that of
the SURP1 domain (Figures 3C and 3D). The a1, a2, a3,
and 310 helices are formed by Ala161-Asn177, Arg179-
Lys188, Leu204-Tyr215, and Tyr193-Leu198, respec-
tively (Figures 1 and 3D). The core-forming hydrophobic
residues (Phe197 and Leu198 in the 310 helix and Phe208
in the a3 helix) adopt a similar spatial relationship as that
in SURP1 (Figure 4B). The peptide (71–107) from SF3a60
forms an amphipathic a helix (denoted as the aA helix
hereafter), composed of Glu80p-Arg96p (the residue
numbers followed by ‘‘p [peptide]’’ are those from the
SF3a60 peptide), upon binding to the SURP2 domain
(Figure 3D). The aA helix of SF3a60 mainly interacts
with the a1 helix of SF3a120 and is located in an anti-
parallel orientation relative to the a1 helix of SURP2
(Figure 3D). The aA helix in SF3a60 also contacts the a2
and 310 helices in SURP2.
The detailed interactions between the SURP2 domain
and the SF3a60 fragment are as follows (Figure 5A). The
hydrophobic amino acids of the SF3a60 fragment
(Phe81p, Phe84p, Leu88p, and Ile91p) are aligned on he-
lix A and interact with the SURP2 domain. The anchoring
Solution Structure of SURP Domains in SF3a120
1681Figure 3. Overall Structures of the Human SF3a120 SURP1 Domain and the SURP2 Domain in Complex with the SF3a60 Fragment
(A) The superimposed, 20 lowest-energy conformers of the SURP1 domain (48–110). Blue lines represent Ca traces.
(B) Ribbon representation of SF3a120 SURP1.
(C) The superimposed, 20 lowest-energy conformers of the SURP2 domain (153–217) in complex with SF3a60 (78–100). The blue and pink lines
represent Ca traces of SF3a120 SURP2 and SF3a60, respectively.
(D) Ribbon representation of SF3a120 SURP2 in complex with SF3a60. The blue and pink helices represent SF3a120 SURP2 and SF3a60,
respectively.point of the peptide is Phe81p, located near the turn of a1
and a2. The aromatic side chain of Phe81p fits well into
the pocket composed of the side chains of Phe181,
Gln184, Leu185, and Lys188, which are all located on
the a2 helix. Val166, Leu169, Thr170, and Phe173 on
a1, Phe181 and Leu185 on a2, and Phe195 on the 310 he-
lix form a shallow groove for the recognition of Phe84p
and Leu88p of helix A. Furthermore, the side chain of
Ile91p on helix A also fits well in the pocket composed
of Phe162, Asp165, Val166, and Leu169 on a1. In sum-
mary, each hydrophobic amino acid on helix aA of the
SF3a60 fragment intimately contacts a corresponding
hydrophobic amino acid on SURP2, thus providing a zip-
per-like binding interaction (Phe81p-Phe181, Phe84p-
Phe173, Leu88p-Leu169, and Ile91p-Phe162, respec-
tively) (Figures 5A and 5B). Additionally, the hydrophilic
residues of SF3a120 a1 (Asn177, Thr170, and Asp165)
and SF3a60 aA (Gln80p, Gln83p, Tyr85p, Arg87p,
Lys92p, and His95p) are involved in the intermolecular
interactions of these two closely aligned a helices (Fig-
ures 5A and 5B).
A comparison of the location of the hydrophobic resi-
dues on the surface of SURP2 with that of SURP1 re-
vealed a large hydrophobic patch on the surface ofSURP2 (Figure 6B), while SURP1 has only a smaller hy-
drophobic area (Figure 6A). The network of these hydro-
phobic interactions fixes the SF3a60 aA helix tightly on
the surface of SURP2.
Mutational Analyses Revealed the Crucial Residue
of the SURP2 Domain for Complex Formation
SF3a60 bound to the surface of SURP2 composed of the
a1, a2, and 310 helices. Interestingly, as shown in Fig-
ure 1, the majority of the residues in SURP2 that interact
with the SF3a60 fragment are conserved or semicon-
served in SURP1 (Figures 1 and 5B), except for three
hydrophilic residues, Asp165, Gln184, and Lys188, and
two hydrophobic amino acid residues, Phe162 and
Leu169. Phe162 and Leu169 have more intimate con-
tacts with the SF3a60 peptide than Asp165, Gln184,
and Lys188 (Figure 5A). Furthermore, the corresponding
positions for Phe162 and Leu169 of SURP2 are occupied
by amino acids with very different properties in SURP1
(charged amino acids: Glu48 and Lys55, respectively)
(Figure 1), while the counterparts for Asp165, Gln184,
and Lys188 of SURP2 have relatively similar properties
in SURP1 (hydrophilic amino acids: Asn51, Arg70, and
Asn74, respectively) (Figure 1). Importantly, Phe162
Structure
1682Figure 4. Hydrophobic-Core Formation of
the SURP Domains of SF3a120
(A) Ribbon representation of the hydrophobic
core of SF3a120 SURP1. The a helices are
colored green. Side chains of the core-form-
ing residues (Phe83, Leu84, and Tyr94) are
represented in orange, and those of the
core-associated residues are represented in
blue. Red letters indicate residues on the
310 helix.
(B) Hydrophobic core of SF3a120 SURP2.
The representation code is the same as in (A).and Leu169 of SURP2 are involved in the formation of
a wider hydrophobic interface for SF3a60, as compared
to the corresponding region in SURP1 (Figures 6A and
6B). Given the above results, these residues were further
examined to identify their roles in domain solubility and
complex formation.
We swapped these residues between SURP1 and
SURP2 by site-directed mutagenesis. Glu48 and Lys55
of SURP1 were swapped with Phe and Leu, which are
the corresponding residues in SURP2 (F162 and L169),
respectively. TheE. colicells expressing the GST-tagged
wild-type or mutant SURP1 domain were lysed by soni-
cation, and the supernatant and pellet fractions were an-
alyzed by 15%–25% polyacrylamide-gel electrophoresis
(PAGE) (see Experimental Procedures). As shown in Fig-
ure 7A, when one of the charged residues in SURP1,
Glu48, was replaced with phenylalanine (E48F mutant),
the insoluble fraction of SURP1 increased. The mutation
of another charged residue (Lys55; the K55L mutant)
caused a severe deficiency in solubility, and the double
mutation (E48F/K55L) made SURP1 completely insolu-
ble. TheE. colicells were then transformed with plasmids
encoding the His-tagged SF3a60 fragment (71–107) and
the GST-tagged wild-type or mutant SURP1 domains.
The cell lysates were analyzed by 15%–25% PAGE and
were purified with Glutathione Sepharose (Figures 7C
and 7E). As described above, the wild-type SURP1 was
soluble (Figure 7C) and exhibited no affinity for the
SF3a60 fragment (Figure 7E). The E48F mutant of
SURP1 coexpressed with SF3a60 was predominantly
soluble (Figure 7C) and also exhibited no affinity for the
SF3a60 fragment, as in the case of the wild-type SURP1
(Figure 7E). Surprisingly, the K55L mutant of SURP1,
which was insoluble when expressed alone inE. coli cells(Figure 7A), became soluble with the coexpression sys-
tem (Figure 7C), and a significant amount of the stained
band corresponding to the SF3a60 fragment was ob-
served by the GST pull-down assay (Figure 7E). Similarly,
the double mutant E48F/K55L showed SF3a60-binding
ability (Figure 7E). These facts clearly indicate that the
single K55L mutation provides SURP1 with the ability to
form a complex with the SF3a60 fragment.
On the other hand, when both of the hydrophobic res-
idues (Phe162 and Leu169) in the SURP2 domain were
replaced with the corresponding charged residues of
SURP1 (F162E/L169K), a portion of the expressed mu-
tant SURP2 domain was soluble (Figure 7B), although
both of the single mutants (F162E and L169K) had al-
most the same solubility as that of the wild-type under
those conditions (Figure 7B). Furthermore, the soluble
fraction of the L169K mutant of SURP2 lost its affinity
for the SF3a60 fragment (71–107), while the F162E mu-
tant of SURP2 showed normal complex-formation abil-
ity (Figure 7F). The L169K mutant of SURP2 was partially
digested by endogenous bacterial proteases (Figures
7D and 7F), suggesting the importance of complex for-
mation with SF3a60 for the stability of SURP2. More-
over, the double mutant (F162E/L169K), which was
more soluble than the single L169K mutant, also showed
no affinity for the SF3a60 fragment (71–107), similar to
the L169K mutant (Figures 7D and 7F). These results in-
dicate that Leu169, but not Phe162, is indispensable for
SURP2 to form the complex with SF3a60.
Collectively, the mutational analyses performed on
SURP1 and SURP2 clearly showed that the positions
that correspond to Lys55 in SURP1 and Leu169 in
SURP2 are critical for the complex formation. It is a re-
markable fact that the exchange of just a single amino
Solution Structure of SURP Domains in SF3a120
1683Figure 5. Complex Formation between SF3a120 SURP2 and SF3a60
(A) Ribbon representation of the complex forming interactions. The a helices of SURP2 and SF3a60 are colored green and pink, respectively. The
side chains of the hydrophobic residues in SF3a120 and SF3a60 are represented in blue and magenta, respectively. The side chains of the non-
hydrophobic residues in SF3a120 and SF3a60 are represented with cyan and orange sticks, respectively. Note that the hydrophobic residues in
both of the proteins are positioned along the a helices, forming a zipper-like structure.
(B) Schematic diagram of the intermolecular NOEs between SF3a120 SURP2 and SF3a60. The numbers of intermolecular NOEs are indicated by
the red numbers and are represented schematically by the line widths.acid completely swapped the complex formation ability
as well as the solubility between SURP1 and SURP2.
Discussion
The SF3a120 protein contains two tandem SURP
domains. The SF3a120 SURP2, but not SURP1, is re-
sponsible for the assembly of the SF3a complex throughbinding to SF3a60. To reveal the structural basis for the
specific interaction mediated by SURP2, we determined
the solution structure of human SF3a120 SURP1 and that
of SURP2 in complex with the SF3a60 fragment (71–107)
by heteronuclear NMR spectroscopy. The SURP domain
adopts a fold with an a1-a2-310-a3 topology. Searches in
the Protein Data Bank (PDB) using the Dali and CE pro-
grams revealed no entries with structural similarity to
Structure
1684Figure 6. Surface Properties of the SF3a120
SURP1 and SURP2 Domains
(A and B) The locations of the hydrophobic
residues on the surfaces of SURP1 (48–103)
(A) and SURP2 (160–217) (B). The hydropho-
bic residues (Ala, Ile, Leu, Met, Phe, Pro,
Trp, and Val) are colored green. The a helix
of the SF3a60 fragment (78p–100p) is repre-
sented by a magenta ribbon.
(C) Comparison of the aromatic residues on
the SF3a60-binding surface of the SF3a120
SURP2 domain. The yellow, green, and pink
ribbons represent the main chains of SURP1
and SURP2 of SF3a120 and the SF3a60 frag-
ment, respectively. The side chains of the
two aromatic residues that undergo a confor-
mational change between the SURP1 (Phe59
and Phe67) and SURP2 (Phe173 and Phe181)
domains are shown in orange and blue.
(D–I) The electrostatic surface potentials of
SURP1 (D and G) and SURP2 (E, F, H, and I).
The SF3a60-binding side of SURP2 (E) and
its counterpart in SURP1 (D),with the opposite
sides shown in (H) and (G), respectively. The
positive and negative charges are colored
blue and red, respectively. The main chain of
the SF3a60 peptide is represented by a ma-
genta coil. (F and I) The electrostatic surface
potentials of the SURP2 domain in complex
with the SF3a60 peptide. The viewpoint is ro-
tated by 45 along the y axis as compared to
that of (E).the SURP domain (Holm and Sander, 1995, 1996; Shin-
dyalov and Bourne, 1998). Furthermore, the folding to-
pology of the SURP domain is totally different from that
of any other mRNA associated domain composed of
only a helices, such as PWI, TPR and the Prp18 func-
tional domain (Fukuhara et al., 2005; Jiang et al., 2000;
Szymczyna et al., 2003). A precise comparison between
SURP1 and SURP2 revealed the peculiarity of SURP2.
The SURP2 holds SF3a60 tightly on its hydrophobic sur-
face. A single Leu residue (Leu169) of SURP2 is the crit-
ical determinant for complex formation. These interac-
tions fix the spatial relationship between the SF3a120
and SF3a60 subunits and may contribute to the assem-
bly of the SF3a complex.
To gain further insight into the SURP domains, first, we
searched for SURP-containing proteins in the SMART
database (Letunic et al., 2006) and identified six proteins
in the human genome, SF3a120, SR140, SWAP, CHERP,
SF4, and SFRS14, which are all splicing-associated pro-
teins (Figure 8A). In addition, as listed in Figure 8A, we
searched for the corresponding ortholog of each protein
in other species for which all of the genomic information
is available. Figure 8A indicates that the number of
(putative) SURP-containing proteins in the genomes
increases according to the evolutional process; espe-
cially, it varies greatly among animals. Among the
SURP-containing proteins, only SF3a120 is found in all
species. SF3a120 is a constitutive splicing factor, in con-
trast to the other proteins, which are regulatory factors.
These results suggest that SF3a120 is the most ancestral
protein and that the SURP domains of SF3a120 diversi-
fied during evolution, perhaps along with the increased
complexity of gene regulatory systems, including splic-
ing. The consensus residues among all of the SURPdomains listed in Figure 8A were analyzed with profile
hidden Markov models (Schuster-Bockler et al., 2004),
and 12 highly conserved residues were found among
56 amino acid residues (Figure 8B). These consensus
residues are conserved in both of the SURP domains in
SF3a120, with a few exceptions (Figure 1). They play an
important role in the formation of the ternary structure
of the SURP domain (Figure 1).
The differences in the properties of the two SURP do-
mains from SF3a120 are considerable: SURP1 is soluble
and has no protein binding activity, while SURP2 is insol-
uble by itself and is solubilized upon binding to the
SF3a60 peptide. However, unexpectedly, a comparison
between the structures of SURP1 and the SURP2-
SF3a60 complex revealed that the composition of amino
acids constituting the protein-binding surface of SURP2
was quite similar to the counterpart in SURP1, with few
exceptions (Figures 1, 6A, and 6B). Strikingly, the pro-
tein-binding activity for SF3a60 could be swapped com-
pletely between the two SURP domains by the substitu-
tion of a single key amino acid residue (Lys55 in SURP1
and Leu169 in SURP2). Detailed comparisons between
the features of the SF3a60-binding site on SURP2 and
those of the corresponding region in SURP1 revealed dif-
ferences in the conformations of the conserved aromatic
residues (Figure 6C), in addition to the change of the key
amino acid. While the main-chain structures are essen-
tially identical between the two SURP domains, the
side chains of two aromatic residues in SURP2 (Phe173
and Phe181) are properly oriented for the formation of
the hydrophobic patch that captures the SF3a60 pep-
tide. These two aromatic amino acids are conserved in
SURP1. However, their conformations are quite different
from those in SURP2 (Figure 6C): thec1 angles of Phe173
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(A) Effect on the solubility of the SURP1 domain by the mutations of Glu48 and Lys55. The crude extracts of the E. coli cells that expressed the
indicated mutant or wild-type SURP1 domains were analyzed by SDS-PAGE and stained with Coomassie brilliant blue dye. The soluble (S) and
precipitated (P) fractions are shown side by side.
(B) Effect on the solubility of the SURP2 domain by the mutations of Phe162 and Leu169. Note that the E. coli cells expressing the SURP1 and
SURP2 domains alone were analyzed in (A) and (B), respectively.
(C) Effect on the solubility of the SURP1 domain in the presence of the SF3a60 peptide by the mutations of Glu48 and Lys55. The crude extracts of
the E. coli cells that coexpressed the wild-type or mutant SURP1 domain and the wild-type SF3a60 peptide were analyzed by SDS-PAGE.
(D) Effect on the solubility of the SURP2 domain in the presence of the SF3a60 peptide by the mutations of Phe162 and Leu169.
(E) GST pull-down assay of SURP1 and SF3a60. The cell lysates of E. coli coexpressing the GST-tagged wild-type/mutant SF3a120
SURP1 and the His-tagged SF3a60 were mixed with Glutathione Sepharose, and the protein fractions bound to the resin were analyzed by
SDS-PAGE.
(F) GST pull-down assay of SURP2 and SF3a60. The cell lysates of E. coli coexpressing the GST-tagged wild-type/mutant SF3a120
SURP2 and the His-tagged SF3a60 were mixed with Glutathione Sepharose, and the protein fractions bound to the resin were analyzed by
SDS-PAGE.and Phe181 in SURP2 are approximately 180 and260,
respectively, while those of Phe59 and Phe67 in SURP1
are approximately 260 and 180, respectively. The
SURP1 domain of SF3a120 also has the potential to
bind with the SF3a60 peptide, as a conformational
change of the conserved aromatic amino acid residues
could generate the binding surface. Our mutational
experiments clearly showed that the SURP1 domain
gained the protein-binding function through the substi-
tution of just one crucial residue. There has been no re-
port about the protein-protein interactions mediated by
the SURP1 domain of SF3a120. However, it is probable
that the Lys55 residue of the SURP1 domain contacts
other molecules, like proteins or nucleic acids, which
have aromatic and acidic properties on the surface,thus forming the cation-p and electrostatic interactions,
respectively.
The difference in the properties of the two SURP do-
mains fromSF3a120 may reflect their molecular evolution.
We performed a phylogenic analysis and found that the
SURP domains are divided into two major subgroups
(termed subgroups 1 and 2 hereafter) (Figure 8C). The se-
quence identities among the human SURP domains
withinsubgroups 1 and 2 are 38%62%and 36%, respec-
tively, whereas that between the two subgroups is 24%6
6%. The SURP1 and SURP2 domains from SF3a120 be-
long to subgroups 1 and 2, respectively. Intriguingly, the
SURP domains that appear only in animals (CHERP,
SF4, and SFRS14) and the SURP domain of SR140 are in-
cluded in subgroup 1 (Figure 8C). It seems reasonable to
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(A) SURP-containing proteins in eukaryotes.
(B) HMM-logo format representation of the amino acid conservation in the SURP domains. The sequence information of all of the SURP domains
shown in (A) was analyzed by the HMMER program (Schuster-Bockler et al., 2004). Asterisks indicate highly conserved residues among the
SURP domains. The red arrowhead indicates the critical position for the complex formation.
(C) Phylogenic tree of the SURP domains. All of the SURP domains shown in (A) are included. The colors of the letters reflect the amino acid type
of the critical residues for the complex formation (Leu169 in the SURP2 domain on human SF3a120); red, blue, and green letters represent
hydrophobic (protein-binding type), charged, and neutral (S, T, and Q) amino acids in the positions, respectively.speculate that these SURP domains were generated from
SURP1 of SF3a120 during evolution. Actually, the key
amino-acid residues (corresponding to Lys55 in SURP1
and Leu169 in SURP2) on a1 of these SURP domains
are hydrophilic: in many cases the key position is occu-
pied by a positively charged amino acid and even ina few exceptions, a Gln, Ser, or Thr residue is located
there. These hydrophilic residues probably enhance the
solubility and stability of the SURP domains in subgroup
1, and as a result, the SURP domains with these residues
diversified in the genomes during animal evolution.
The SURP1 domain of SWAP is closer to SURP2 of
Solution Structure of SURP Domains in SF3a120
1687SF3a120, as compared to SURP1 of SF3a120, in the phy-
logenic tree (Figure 8C). However, it also has a charged
amino acid residue (Arg214) at the critical position (Fig-
ure 1). This suggests that the SURP1 domain of SWAP
may resemble the L169R mutant of SURP2 in SF3a120
and that it has intermediate properties between those of
SURP1 and SURP2 from SF3a120. Consequently, the
critical Leu residue is restricted to the SF3a120 SURP2.
Consistent with this fact, only the SURP2 domain plays
an important role in the SF3a complex assembly.
The SURP-containing proteins are found exclusively
in splicing factors. This provides a hint about their
common functions: they could serve as RNA-binding
domains. A UV cross-linking analysis revealed that
SF3a120 binds to the upstream region of the branch
point of pre-mRNA, but not to U2 snRNA (Gozani et al.,
1996). Moreover, one of the sterile a motif (SAM) do-
mains (Ponting, 1995), which had originally been de-
scribed as a protein-binding domain, has a positively
charged patch on its surface and binds to a stem-loop
RNA (Oberstrass et al., 2006). As shown in Figures 6D–
6I, the SURP1 and SURP2 domains of SF3a120 have
positive charges on their surfaces. Furthermore, a new
positively charged patch is formed in the groove be-
tween SURP2 and helix A of SF3a60 (Figures 6F and
6I). These findings raise the possibility that although
the SURP2 domain has a peptide-binding function, the
SURP domains of SF3a120 may also have an RNA-bind-
ing activity through the positively charged patch. There-
fore, we examined whether the SF3a120 fragment
(48–217), containing both of the SURP domains com-
plexed with the SF3a60 peptide (71–107), binds to the
RNA 12–25 nucleotides upstream from the branch point
of the pre-mRNA, with the sequence GGG UUU CCU
UGA AG, by using an ultrasensitive isothermal titration
calorimeter (VP-ITC, Microcal). However, the protein
complex showed no binding to the RNA (data not
shown). It is probable that the SURP domains in
SF3a120 bind to structured RNA, like the SAM domain.
In the present study, we revealed the structural basis
for the specific interaction between SF3a60 and
SF3a120 mediated by the SURP domain. To gain further
insight into the molecular assembly of the SF3a complex
and the U2 snRNP in the spliceosome, more structural
information is necessary. Work is now in progress to
analyze the SF3a-RNA interaction, which will reveal the
common functions of the SURP domains.
Experimental Procedures
Expression of Recombinant Proteins
The cDNAs encoding the fragments of human SF3a60 (Accession
number: Q12874) (1–107, 1–70, 1–35, 36–107, 36–70, and 71–107)
and the cDNAs encoding the fragments of human SF3a120 (Acces-
sion number: Q15459) (48–217, 48–157, 48–110, 111–157, 111–217,
134–217, and 158–217) were cloned in the plasmid vector
pGEX6P-1 (GE Healthcare) and/or the plasmid vector pET-15b (No-
vagen). In both constructs, the TEV protease cleavage site (Glu-Asn-
Leu-Tyr-Phe-Gln-Gly, encoded by gaaaacctgtatttccagggc) was
placed between the tag and protein sequences. The TEV protease
cleaves the amide bond of the Gln-Gly dipeptide, resulting in an
additional Gly residue at the N terminus of each construct.
For the coexpression system of SF3a60 and SF3a120, the cDNA
encoding each SF3a120 fragment was cloned into the pGEX6p-1
plasmid, with the TEV cleavage site between GST and SF3a120.
The cDNA encoding each His-tagged SF3a60 fragment, with theTEV cleavage site between the His-tag and SF3a60, was cloned
into the downstream region of the aforementioned pGEX6p-1-
SF3a120 plasmid. The ribosomal binding site (RBS: gaaggag) was
placed between the stop codon of SF3a120 and the start codon of
the downstream SF3a60 cDNA. In the same way, the coexpression
vectors for the GST-tagged SF3a60 and the His-tagged SF3a120
were constructed.
E. coli strain BL21 (DE3) cells were transformed with the recombi-
nant plasmids and grown at 37C in 2 3 YT medium supplemented
with 50 mg/l ampicillin. IPTG was added to the culture to a final con-
centration of 1 mM, to induce protein expression. After 4–5 hr of cul-
tivation, the cells were harvested and were lysed by sonication in
a phosphate buffer containing 1 mM DTT, 1 mM PMSF, and protease
inhibitor cocktail for general use (Nacalai Tesque). The lysates were
centrifuged at 17,0003 g for 10 min at 4C to separate the superna-
tant and pellet. The protein solubility was assessed by SDS poly-
acrylamide gel electrophoresis analyses of the lysates.
Preparation of the SF3a120 SURP1 Domain for Structure
Determination
To obtain the 15N,13C-labeled recombinant His-tagged SURP1 do-
main of SF3a120, E. coli strain BL21 (DE3) cells, transformed with
the pET15b-SF3a120 SURP1 (48–110), were cultivated at 37C as de-
scribed above, except for the use of modified minimum medium
(15 g/l Na2HPO4, 6 g/l KH2PO4, 5 g/l NaCl, 1 g/l
15N-NH4Cl, 4 g/l
13C-glucose, 0.12 g/l MgSO4, 11.88 mg/l FeSO4, 2 mg/l thiamine hy-
drochloride, 2 mg/l D-biotin, 2.65 mg/l CaCl2, 57.15 mg/l citric acid)
supplemented with 50 mg/l ampicillin. The harvested culture was
lysed as described above. The lysate was applied to a Ni-NTA Super-
Flow (Qiagen) column with an imidazole gradient from 20 mM to 250
mM, and the tag was removed by an incubation with TEV protease
overnight at room temperature. The tag-free SURP1 was further
purified by RESOURCE S column chromatography (GE Healthcare).
Preparation of the SF3a60-SF3a120 SURP2 Domain Complex
for Structure Determination
For the structure determination of the SF3a120 SURP2-SF3a60 com-
plex, we prepared the 15N,13C -labeled recombinant His-tagged
SF3a120 SURP2 (134–217) and the GST-tagged SF3a60 (71–107)
proteins by using the coexpression system. E. coli strain BL21
(DE3) cells, transformed with the coexpression plasmid vector
pGEX6p-1-SF3a60 (71–107)-His(6)-SF3a120 SURP2 (134–217),
were cultivated, harvested, and lysed in the same way as in the prep-
aration of the 15N,13C-labeled SURP1 domain. The lysate was applied
to a Glutathione Sepharose 4 Fast Flow (GE Healthcare) column and
was eluted by 10 mM reduced glutathione. The eluate was further pu-
rified by chromatography on Ni-NTA SuperFlow with an imidazole
gradient from 20 mM to 250 mM, and the His and GST tags were re-
moved by an incubation with TEV-protease overnight at room tem-
perature. The tag-free complex was further purified by RESOURCE
S column chromatography.
NMR Spectroscopy
The protein samples for NMR measurements were concentrated to
approximately 2.0 mM, in 20 mM sodium phosphate buffer (pH 6.0
and 7.0) containing 1 mM 1,4-DL-dithiothreitol-d10 (d-DTT) dissolved
in 90% 1H2O/10%
2H2O, by using a Vivaspin 20 ml concentrator
(membrane: 3000 MWCO PES, Vivascience).
NMR experiments were performed at 5C for the SURP1 domain
and 35C for the SURP2 domain on Bruker 700 MHz and 800 MHz
spectrometers (Bruker AV700 and Bruker AV 800), respectively.
1H, 15N, and 13C chemical shifts were referenced relative to the fre-
quency of the 2H lock resonance of water. Main-chain and side-
chain assignments were obtained from a combination of standard
triple resonance experiments (Bax and Saxena, 1994; Kay, 1997).
2D [1H, 15N]-HSQC and 3D [1H, 15N, 13C]-HNCO, HN(CA)CO, HNCA,
HN(CO)CA, HNCACB, and CBCA(CO)NH spectra were used for the
1H, 15N, and 13C assignments of the main chain. Side-chain 1H and
13C assignments of the nonaromatic residues were obtained with
2D [1H, 13C]-HSQC, 3D HBHA(CO)NH, H(CCCO)NH, (H)CC(CO)NH,
HCCH-COSY, HCCH-TOCSY, (H)CCH-TOCSY spectra. Assign-
ments were confirmed with the 3D 15N-edited [1H, 1H]-NOESY and
13C-edited [1H, 1H]-NOESY spectra. The 1H and 13C spin systems
of the aromatic rings of Phe, Trp, His, and Tyr were identified by
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ted [1H, 1H]-NOESY was used for the establishment of the sequence-
specific resonance assignments of aromatic side chains. All NOESY
spectra were recorded with mixing times of 80–150 ms. The 2D and
3D spectra were processed by using NMRPipe (Delaglio et al., 1995).
Analyses of the processed data were performed with the programs
NMRView (Johnson, 2004) and KUJIRA (N. Kobayashi, personal
communication).
Structure Calculations
The three-dimensional structures of the protein and the protein-pep-
tide complex were determined by combined automated NOESY
cross-peak assignment (Herrmann et al., 2002) and structure calcu-
lations with torsion-angle dynamics (Gu¨ntert et al., 1997) imple-
mented in the program CYANA 2.1 (Gu¨ntert, 2004). Dihedral angle
constraints for f and c were obtained from the main chain and
13Cb chemical-shift values with the program TALOS (Cornilescu
et al., 1999) and by analyzing the NOESY spectra. Structure calcula-
tions started from 100 randomized conformers and used the stan-
dard CYANA simulated annealing schedule (Gu¨ntert et al., 1997).
The 20 conformers with the lowest final CYANA target function
values were subjected to restrained energy minimization in a water
shell with the program OPALp (Koradi et al., 2000) by using the
AMBER force field (Cornell et al., 1995). PROCHECK-NMR (Laskow-
ski et al., 1996) and MOLMOL (Koradi et al., 1996) were used to
validate and to visualize the final structures, respectively.
Mutational Analysis
Point mutations were introduced into GST-tagged SURP1 (48–110)
and SURP2 (134–217) from SF3a120 by PCR, with 28- to 30-mer
primers spanning the site of the desired mutation, as described
(Ito et al., 1991). Mutations were confirmed by sequencing. The sol-
ubility of the mutant proteins was assessed as described above. To
examine the complex-formation ability of these mutant proteins,
His-tagged SF3a60 (71–107) and the GST-tagged SF3a120 mutants
were coexpressed in E. coli cells. A 200 ml volume of the cell lysate
was mixed with a 5 ml volume of the Glutathione Sepharose resin
for 30 min at 4C, and then the resin was washed five times with
PBS containing 0.05% Nonidet P-40 (Nacalai Tesque). The proteins
bound to the resin were analyzed by SDS-PAGE.
Informatics Analyses to Search for SURP Domains
We identified nine SURP-containing proteins in the human genome,
accessed in the SMART database (Letunic et al., 2006), and removed
the redundancy of the entries based on the cut-off value = 100% ho-
mology. As a result, six proteins were identified as SURP-containing
proteins. The orthologs of the human SURP-containing proteins
were obtained from the entries in the SMART database, as described
above. Their amino acid sequences were aligned and used to create
a phylogenic tree with the ClustalX software (Jeanmougin et al.,
1998). The consensus residues among all of the SURP domains
were analyzed with the profile hidden Markov models (Schuster-
Bockler et al., 2004).
Acknowledgments
We are grateful to Dr. N. Kobayashi for help with the NMR data
analysis and structure calculations. We would like to thank Mr. T.
Tomizawa for help with the VP-ITC operation and Mr. N. Tochio for
software implementation. We would like to acknowledge Dr. K. Kur-
imoto for discussions and critical reading of the manuscript. We
would like to thank Ms. A. Ishii, Ms. K. Yajima, and Ms. T. Nakayama
for help with the preparation of the manuscript. This work was sup-
ported by the RIKEN Structural Genomics/Proteomics Initiative
(RSGI) of the National Project on Protein Structural and Functional
Analyses, the Ministry of Education, Culture, Sports, Science and
Technology of Japan. This work was also supported by a grant
from the Human Frontier Science Program (H.F.S.P.) to the Muto
research group.
Received: August 10, 2006
Revised: September 4, 2006
Accepted: September 9, 2006
Published: November 14, 2006References
Bax, W.A., and Saxena, P.R. (1994). The current endothelin receptor
classification: time for reconsideration? Trends Pharmacol. Sci. 15,
379–386.
Brosi, R., Groning, K., Behrens, S.E., Lu¨hrmann, R., and Kra¨mer, A.
(1993). Interaction of mammalian splicing factor SF3a with U2
snRNP and relation of its 60-kD subunit to yeast PRP9. Science
262, 102–105.
Caspary, F., and Se´raphin, B. (1998). The yeast U2A0/U2B00 complex
is required for pre-spliceosome formation. EMBO J. 17, 6348–6358.
Chiara, M.D., Champion-Arnaud, P., Buvoli, M., Nadal-Ginard, B.,
and Reed, R. (1994). Specific protein-protein interactions between
the essential mammalian spliceosome-associated proteins SAP 61
and SAP 114. Proc. Natl. Acad. Sci. USA 91, 6403–6407.
Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Jr.,
Ferguson, D.M., Spellmeyer, D.C., Fox, T., Cajdwell, J.W., and Koll-
man, P.A. (1995). A second generation force field for the simulation
of proteins, nucleic acids, and organic molecules. J. Am. Chem.
Soc. 117, 5179–5197.
Cornilescu, G., Delaglio, F., and Bax, A. (1999). Protein backbone
angle restraints from searching a database for chemical shift and
sequence homology. J. Biomol. NMR 13, 289–302.
Das, B.K., Xia, L., Palandjian, L., Gozani, O., Chyung, Y., and Reed, R.
(1999). Characterization of a protein complex containing spliceoso-
mal proteins SAPs 49, 130, 145, and 155. Mol. Cell. Biol. 19, 6796–
6802.
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax,
A. (1995). NMRPipe: a multidimensional spectral processing system
based on UNIX pipes. J. Biomol. NMR 6, 277–293.
Denhez, F., and Lafyatis, R. (1994). Conservation of regulated alter-
native splicing and identification of functional domains in vertebrate
homologs to theDrosophila splicing regulator, suppressor-of-white-
apricot. J. Biol. Chem. 269, 16170–16179.
Dziembowski, A., Ventura, A.P., Rutz, B., Caspary, F., Faux, C., Hal-
gand, F., Laprevote, O., and Se´raphin, B. (2004). Proteomic analysis
identifies a new complex required for nuclear pre-mRNA retention
and splicing. EMBO J. 23, 4847–4856.
Fukuhara, N., Ebert, J., Unterholzner, L., Lindner, D., Izaurralde, E.,
and Conti, E. (2005). SMG7 is a 14-3-3-like adaptor in the non-
sense-mediated mRNA decay pathway. Mol. Cell 17, 537–547.
Gozani, O., Feld, R., and Reed, R. (1996). Evidence that sequence-
independent binding of highly conserved U2 snRNP proteins up-
stream of the branch site is required for assembly of spliceosomal
complex A. Genes Dev. 10, 233–243.
Gu¨ntert, P. (2004). Automated NMR structure calculation with
CYANA. Methods Mol. Biol. 278, 353–378.
Gu¨ntert, P., Mumenthaler, C., and Wu¨thrich, K. (1997). Torsion angle
dynamics for NMR structure calculation with the new program
DYANA. J. Mol. Biol. 273, 283–298.
Hastings, M.L., and Krainer, A.R. (2001). Pre-mRNA splicing in the
new millennium. Curr. Opin. Cell Biol. 13, 302–309.
Herrmann, T., Gu¨ntert, P., and Wu¨thrich, K. (2002). Protein NMR
structure determination with automated NOE assignment using the
new software CANDID and the torsion angle dynamics algorithm
DYANA. J. Mol. Biol. 319, 209–227.
Holm, L., and Sander, C. (1995). Dali: a network tool for protein struc-
ture comparison. Trends Biochem. Sci. 20, 478–480.
Holm, L., and Sander, C. (1996). The FSSP database: fold classifica-
tion based on structure-structure alignment of proteins. Nucleic
Acids Res. 24, 206–209.
Ito, W., Ishiguro, H., and Kurosawa, Y. (1991). A general method for
introducing a series of mutations into cloned DNA using the poly-
merase chain reaction. Gene 102, 67–70.
Jeanmougin, F., Thompson, J.D., Gouy, M., Higgins, D.G., and Gib-
son, T.J. (1998). Multiple sequence alignment with Clustal X. Trends
Biochem. Sci. 23, 403–405.
Jiang, J., Horowitz, D.S., and Xu, R.M. (2000). Crystal structure of the
functional domain of the splicing factor Prp18. Proc. Natl. Acad. Sci.
USA 97, 3022–3027.
Solution Structure of SURP Domains in SF3a120
1689Johnson, B.A. (2004). Using NMRView to visualize and analyze the
NMR spectra of macromolecules. Methods Mol. Biol. 278, 313–352.
Jurica, M.S., and Moore, M.J. (2003). Pre-mRNA splicing: awash in
a sea of proteins. Mol. Cell 12, 5–14.
Kambach, C., Walke, S., Young, R., Avis, J.M., de la Fortelle, E.,
Raker, V.A., Lu¨hrmann, R., Li, J., and Nagai, K. (1999). Crystal struc-
tures of two Sm protein complexes and their implications for the
assembly of the spliceosomal snRNPs. Cell 96, 375–387.
Kay, L.E. (1997). NMR methods for the study of protein structure and
dynamics. Biochem. Cell Biol. 75, 1–15.
Koradi, R., Billeter, M., and Gu¨ntert, P. (2000). Point-centered do-
main decomposition for parallel molecular dynamics simulation.
Comput. Phys. Commun. 124, 139–147.
Koradi, R., Billeter, M., and Wu¨thrich, K. (1996). MOLMOL: a pro-
gram for display and analysis of macromolecular structures.
J. Mol. Graph. 14, 51–55, 29–32.
Kra¨mer, A. (1996). The structure and function of proteins involved in
mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65, 367–409.
Kra¨mer, A., Legrain, P., Mulhauser, F., Groning, K., Brosi, R., and
Bilbe, G. (1994). Splicing factor SF3a60 is the mammalian homo-
logue of PRP9 of S. cerevisiae: the conserved zinc finger-like motif
is functionally exchangeable in vivo. Nucleic Acids Res. 22, 5223–
5228.
Kra¨mer, A., Mulhauser, F., Wersig, C., Groning, K., and Bilbe, G.
(1995). Mammalian splicing factor SF3a120 represents a new mem-
ber of the SURP family of proteins and is homologous to the essen-
tial splicing factor PRP21p of Saccharomyces cerevisiae. RNA 1,
260–272.
Laskowski, R.A., Rullmann, J.A., MacArthur, M.W., Kaptein, R., and
Thornton, J.M. (1996). AQUA and PROCHECK-NMR: programs for
checking the quality of protein structures solved by NMR. J. Biomol.
NMR 8, 477–486.
Legrain, P., and Chapon, C. (1993). Interaction between PRP11 and
SPP91 yeast splicing factors and characterization of a PRP9-
PRP11-SPP91 complex. Science 262, 108–110.
Letunic, I., Copley, R.R., Pils, B., Pinkert, S., Schultz, J., and Bork, P.
(2006). SMART 5: domains in the context of genomes and networks.
Nucleic Acids Res. 34, D257–D260.
Lu¨hrmann, R., Kastner, B., and Bach, M. (1990). Structure of spliceo-
somal snRNPs and their role in pre-mRNA splicing. Biochim.
Biophys. Acta 1087, 265–292.
Michaud, S., and Reed, R. (1991). An ATP-independent complex
commits pre-mRNA to the mammalian spliceosome assembly
pathway. Genes Dev. 5, 2534–2546.
Nesic, D., and Kra¨mer, A. (2001). Domains in human splicing factors
SF3a60 and SF3a66 required for binding to SF3a120, assembly of
the 17S U2 snRNP, and prespliceosome formation. Mol. Cell. Biol.
21, 6406–6417.
Nilsen, T.W. (2003). The spliceosome: the most complex macromo-
lecular machine in the cell? Bioessays 25, 1147–1149.
Oberstrass, F.C., Lee, A., Stefl, R., Janis, M., Chanfreau, G., and
Allain, F.H. (2006). Shape-specific recognition in the structure of
the Vts1p SAM domain with RNA. Nat. Struct. Mol. Biol. 13, 160–167.
Ponting, C.P. (1995). SAM: a novel motif in yeast sterile and Dro-
sophila polyhomeotic proteins. Protein Sci. 4, 1928–1930.
Price, S.R., Evans, P.R., and Nagai, K. (1998). Crystal structure of the
spliceosomal U2B00-U2A0 protein complex bound to a fragment of U2
small nuclear RNA. Nature 394, 645–650.
Query, C.C., Moore, M.J., and Sharp, P.A. (1994). Branch nucleophile
selection in pre-mRNA splicing: evidence for the bulged duplex
model. Genes Dev. 8, 587–597.
Raker, V.A., Plessel, G., and Lu¨hrmann, R. (1996). The snRNP core
assembly pathway: identification of stable core protein heteromeric
complexes and an snRNP subcore particle in vitro. EMBO J. 15,
2256–2269.
Sampson, N.D., and Hewitt, J.E. (2003). SF4 and SFRS14, two re-
lated putative splicing factors on human chromosome 19p13.11.
Gene 305, 91–100.Sarkissian, M., Winne, A., and Lafyatis, R. (1996). The mammalian
homolog of suppressor-of-white-apricot regulates alternative
mRNA splicing of CD45 exon 4 and fibronectin IIICS. J. Biol.
Chem. 271, 31106–31114.
Scherly, D., Boelens, W., Dathan, N.A., van Venrooij, W.J., and Mat-
taj, I.W. (1990). Major determinants of the specificity of interaction
between small nuclear ribonucleoproteins U1A and U2B00 and their
cognate RNAs. Nature 345, 502–506.
Schuster-Bockler, B., Schultz, J., and Rahmann, S. (2004). HMM
Logos for visualization of protein families. BMC Bioinformatics 5, 7.
Se´raphin, B., Kretzner, L., and Rosbash, M. (1988). A U1 snRNA:pre-
mRNA base pairing interaction is required early in yeast spliceo-
some assembly but does not uniquely define the 50 cleavage site.
EMBO J. 7, 2533–2538.
Shindyalov, I.N., and Bourne, P.E. (1998). Protein structure align-
ment by incremental combinatorial extension (CE) of the optimal
path. Protein Eng. 11, 739–747.
Spikes, D.A., Kra¨mer, J., Bingham, P.M., and Van Doren, K. (1994).
SWAP pre-mRNA splicing regulators are a novel, ancient protein
family sharing a highly conserved sequence motif with the prp21
family of constitutive splicing proteins. Nucleic Acids Res. 22,
4510–4519.
Staley, J.P., and Guthrie, C. (1998). Mechanical devices of the spli-
ceosome: motors, clocks, springs, and things. Cell 92, 315–326.
Szymczyna, B.R., Bowman, J., McCracken, S., Pineda-Lucena, A.,
Lu, Y., Cox, B., Lambermon, M., Graveley, B.R., Arrowsmith, C.H.,
and Blencowe, B.J. (2003). Structure and function of the PWI motif:
a novel nucleic acid-binding domain that facilitates pre-mRNA
processing. Genes Dev. 17, 461–475.
Tang, J., Abovich, N., and Rosbash, M. (1996). Identification and
characterization of a yeast gene encoding the U2 small nuclear ribo-
nucleoprotein particle B00 protein. Mol. Cell. Biol. 16, 2787–2795.
Utans, U., and Kra¨mer, A. (1990). Splicing factor SF4 is dispensable
for the assembly of a functional splicing complex and participates in
the subsequent steps of the splicing reaction. EMBO J. 9, 4119–
4126.
Varani, G., and Nagai, K. (1998). RNA recognition by RNP proteins
during RNA processing. Annu. Rev. Biophys. Biomol. Struct. 27,
407–445.
Wiest, D.K., O’Day, C.L., and Abelson, J. (1996). In vitro studies of the
Prp9.Prp11.Prp21 complex indicate a pathway for U2 small nuclear
ribonucleoprotein activation. J. Biol. Chem. 271, 33268–33276.
Will, C.L., Urlaub, H., Achsel, T., Gentzel, M., Wilm, M., and Lu¨hr-
mann, R. (2002). Characterization of novel SF3b and 17S U2 snRNP
proteins, including a human Prp5p homologue and an SF3b DEAD-
box protein. EMBO J. 21, 4978–4988.
Zhu, J., and Krainer, A.R. (2000). Pre-mRNA splicing in the absence
of an SR protein RS domain. Genes Dev. 14, 3166–3178.
Zhuang, Y., and Weiner, A.M. (1986). A compensatory base change
in U1 snRNA suppresses a 50 splice site mutation. Cell 46, 827–835.
Accession Numbers
The atomic coordinates for the ensemble of 20 NMR structures of
SURP1 and the SURP2-SF3a60 complex have been deposited in
the Protein Data Bank (Accession codes 2DT6 and 2DT7, respec-
tively).
